AbstractPDF
Abstract
Idiopathic thrombocytopenic purpura (ITP) is an immune-mediated thrombocytopenia. The diagnosis is made after exclusion of other secondary causes of
thrombocytopenic disorders. The primary treatment
goal is to prevent severe bleeding rather than achieve
normal platelet counts. In adults ITP usually has an insidious onset and chronic course. Although ITP is a
relatively common haematological disorder, there are
important unresolved issues in its management, especially for chronic refractory ITP patients. New therapeutic agents have changed strategies for ITP treatment.
This article reviews the treatment indications and options of chronic ITP in adults in the literature and compares them with the treatment indications and treatment options used by the Dutch internist.
